Predicting In Vivo Efficacy of Potential Restenosis Therapies by Cell Culture Studies: Species-Dependent Susceptibility of Vascular Smooth Muscle Cells

Por Hila, Epstein, Rabinovich, Laura, Banai, Shmuel, Elazar, Vicktoria, Gao, Jianchuan, Chorny, Michael, Danenebrg, Haim D, Golomb, Gershon
Publicado em 2008

Preparation of Alendronate Liposomes for Enhanced Stability and Bioactivity: In Vitro and In Vivo Characterization

Por Epstein, Hila, Gutman, Dikla, Cohen-Sela, Einat, Haber, Elran, Elmalak, Omar, Koroukhov, Nickolay, Danenberg, Haim D., Golomb, Gershon
Publicado em 2008

Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats

Por Afergan, Eyal, Ben David, Meital, Epstein, Hila, Koroukhov, Nickolay, Gilhar, Dalia, Rohekar, Keren, Danenberg, Haim D., Golomb, Gershon
Publicado em 2010

In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid–polymeric nanoparticles

Por Chan, Juliana M., Rhee, June-Wha, Drum, Chester L., Bronson, Roderick T., Golomb, Gershon, Langer, Robert, Farokhzad, Omid C.
Publicado em 2011

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy

Por Ben-David-Naim, Meital, Dagan, Arie, Grad, Etty, Aizik, Gil, Nordling-David, Mirjam M., Morss Clyne, Alisa, Granot, Zvi, Golomb, Gershon
Publicado no Cancers (Basel) (2019)

Technical Advance: Liposomal alendronate depletes monocytes and macrophages in the nonhuman primate model of human disease

Por Burwitz, Benjamin J., Reed, Jason S., Hammond, Katherine B., Ohme, Merete A., Planer, Shannon L., Legasse, Alfred W., Ericsen, Adam J., Richter, Yoram, Golomb, Gershon, Sacha, Jonah B.
Publicado no J Leukoc Biol (2014)

Spatiotemporal controlled delivery of nanoparticles to injured vasculature

Por Chan, Juliana M., Zhang, Liangfang, Tong, Rong, Ghosh, Debuyati, Gao, Weiwei, Liao, Grace, Yuet, Kai P., Gray, David, Rhee, June-Wha, Cheng, Jianjun, Golomb, Gershon, Libby, Peter, Langer, Robert, Farokhzad, Omid C.
Publicado em 2010